VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...
The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...
A woman's breast tissue undergoes dramatic changes as it ages, creating an environment where cancer cells are more likely to ...
Detailed data for the gedatolisib triplet and doublet regimens will be presented at a late-breaking abstract oral session at the 2026 ASCO Annual Meeting ...
UPPSALA, SE / ACCESS Newswire / April 30, 2026 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) - Biovica ...
Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...
Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ ...
Laura said: "I could see by everyone's face as soon as I removed my bra that they knew what it was. The doctor said there was ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Mexican Institute of Industrial ...
Laura Rowley said there was a moment that 'said it all' ...
The step-mum-of-two was given medication to regulate her hormones, but it didn't stop - and then she began to notice ...
Laura Rowley said she wanted others to be aware of lesser-known symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results